SQA

DECEMBER 16, 2022

SQA Regulatory Surveillance Summary for September and October 2022. ANVISA’s Questions & Answers (Q&A) on Medical Cannabis for Clinical Investigations, 14 September 2022. ANVISA published answers to questions received during an online seminar on clinical research of medicinal cannabis held in May 2022.

FDA 40

FDA Compliance COVID-19 Licensing 40

Hall Render

MARCH 25, 2022

Dr. Lorna Breen Health Care Provider Protection Act becomes law. 28 organizations express gratitude for bill condemning violence against healthcare workers. The historic split of Alaska’s massive health department is now law. Outstanding Women in Business 2022: Get to know Carmen Neuberger of Phoenix Children’s.

COVID-19 40

COVID-19 US Department of Health and Human Services Nursing Homes Nurses 40

SQA

MAY 24, 2023

ANVISA has intercepted international shipments of Batch Number C6835C3 which presented a false description of content and contained bottles in packaging in the Turkish language with expirations dates 10/2024 (bottle) and 12/2024 (secondary packaging). The document will become effective 6 months after publication (10 September 2023).

FDA 40

FDA Licensing Governance Compliance 40

SQA

DECEMBER 10, 2021

Regulators in Europe have updated their implementation plan for sweeping new in-vitro diagnostic (IVD) medical device regulations taking effect in 2022. Pilot Program: EMA-FDA Parallel Scientific Advice for Hybrid/Complex Generic Products – General Principles, 15 September 2021. In-house devices. European Medicines Agency (EMA).

FDA 52

FDA Compliance Public Health Hospitals 52

SQA

FEBRUARY 26, 2024

The action was held from 26 to 28 September 2023, at the city’s international entry points. .” NMPA becomes the applicant for PIC/S 09, November 2023 In late September 2023, the NMPA submitted the formal application to the Pharmaceutical Inspection Co-operation Scheme (PIC/S).

FDA 52

FDA Compliance COVID-19 Public Health 52